chloroquine has been researched along with Allergic Encephalomyelitis in 8 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Thome, R | 6 |
| Boehm, A | 1 |
| Ishikawa, LLW | 1 |
| Casella, G | 1 |
| Munhoz, J | 1 |
| Ciric, B | 1 |
| Zhang, GX | 2 |
| Rostami, A | 2 |
| Bonfanti, AP | 2 |
| Rasouli, J | 1 |
| Mari, ER | 1 |
| Verinaud, L | 5 |
| Moraes, AS | 1 |
| Bombeiro, AL | 3 |
| Farias, Ados S | 1 |
| Francelin, C | 1 |
| da Costa, TA | 4 |
| Di Gangi, R | 3 |
| dos Santos, LM | 1 |
| de Oliveira, AL | 3 |
| Issayama, LK | 3 |
| DiGangi, R | 1 |
| Ferreira, IT | 3 |
| Bhattacharya, A | 1 |
| Parillon, X | 1 |
| Zeng, S | 1 |
| Han, S | 1 |
| Eissa, NT | 1 |
| Zanucoli, F | 1 |
| de Carvalho, AC | 1 |
| Machado, DR | 1 |
| Rapôso, C | 1 |
| Lopes, SC | 1 |
| Longhini, AL | 1 |
| Oliveira, AL | 1 |
| da Cruz Höfling, MA | 1 |
| Costa, FT | 1 |
| Rosenthale, ME | 1 |
| Datko, LJ | 1 |
| Kassarich, J | 1 |
| Schneider, F | 1 |
8 other studies available for chloroquine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Chloroquine reduces Th17 cell differentiation by stimulating T-bet expression in T cells.
Topics: Animals; Antimalarials; Cell Differentiation; Chloroquine; Encephalomyelitis, Autoimmune, Experiment | 2021 |
Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
Topics: Animals; Autoantigens; Cells, Cultured; Chloroquine; Dendritic Cells; Disease Models, Animal; Enceph | 2018 |
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Anti-Inflammatory Agents; Cells, Cultured; Central Nervous System; Chlor | 2013 |
Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Antigen Presentation; Antirheumatic Agents; Cell Proliferation; Chloroqu | 2014 |
Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis.
Topics: Animals; Antigen Presentation; Autophagy; Autophagy-Related Protein 7; CD4-Positive T-Lymphocytes; C | 2014 |
Nitric oxide plays a key role in the suppressive activity of tolerogenic dendritic cells.
Topics: Animals; Antimalarials; Cells, Cultured; Chloroquine; Dendritic Cells; Encephalomyelitis, Autoimmune | 2015 |
Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chloroquine; Encephalomyelitis, Aut | 2014 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; | 1969 |